Hsin-chieh M. Wu

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia.

Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia.

Journal: Leukemia
Published: March 19, 2025

Tripartite RAR fusions explain RA resistance.

Tripartite RAR fusions explain RA resistance.

Journal: Blood
Published: October 03, 2024

Acute Promyelocytic Leukemia, Retinoic Acid, and Arsenic: A Tale of Dualities.

Acute Promyelocytic Leukemia, Retinoic Acid, and Arsenic: A Tale of Dualities.

Journal: Cold Spring Harbor perspectives in medicine
Published: March 19, 2024

In APL, noncoding mutations and SNP converge on WT1.

In APL, noncoding mutations and SNP converge on WT1.

Journal: Blood
Published: May 25, 2022

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML).

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML).

Journal: Biomedicines
Published: September 07, 2021

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.

Journal: Cancer discovery
Published: February 08, 2021

A Pin1/PML/P53 axis activated by retinoic acid in NPM-1c acute myeloid leukemia.

A Pin1/PML/P53 axis activated by retinoic acid in NPM-1c acute myeloid leukemia.

Journal: Haematologica
Published: October 24, 2020

A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA.

A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA.

Journal: Leukemia
Published: July 16, 2020

PML nuclear bodies, membrane-less domains acting as ROS sensors?

PML nuclear bodies, membrane-less domains acting as ROS sensors?

Journal: Seminars in cell & developmental biology
Published: August 28, 2017

Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.

Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.

Journal: Cancer
Published: August 24, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026